Endocrinology and Metabolism (Sep 2015)

Acromegaly with Normal Insulin-Like Growth Factor-1 Levels and Congestive Heart Failure as the First Clinical Manifestation

  • Hyae Min Lee,
  • Sun Hee Lee,
  • In-Ho Yang,
  • In Kyoung Hwang,
  • You Cheol Hwang,
  • Kyu Jeung Ahn,
  • Ho Yeon Chung,
  • Hui-Jeong Hwang,
  • In-Kyung Jeong

DOI
https://doi.org/10.3803/EnM.2015.30.3.395
Journal volume & issue
Vol. 30, no. 3
pp. 395 – 401

Abstract

Read online

The leading cause of morbidity and mortality in patients with acromegaly is cardiovascular complications. Myocardial exposure to excessive growth hormone can cause ventricular hypertrophy, hypertension, arrhythmia, and diastolic dysfunction. However, congestive heart failure as a result of systolic dysfunction is observed only rarely in patients with acromegaly. Most cases of acromegaly exhibit high levels of serum insulin-like growth factor-1 (IGF-1). Acromegaly with normal IGF-1 levels is rare and difficult to diagnose. Here, we report a rare case of an acromegalic patient whose first clinical manifestation was severe congestive heart failure, despite normal IGF-1 levels. We diagnosed acromegaly using a glucose-loading growth hormone suppression test. Cardiac function and myocardial hypertrophy improved 6 months after transsphenoidal resection of a pituitary adenoma.

Keywords